| A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK KJ Phekoo, SA Schey, MA Richards, DH Bevan, S Bell, D Gillett, H Møller, ... British journal of haematology 127 (3), 299-304, 2004 | 168 | 2004 |
| The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England KJ Phekoo, MA Richards, H Moller, SA Schey, ... Haematologica 91 (10), 1400-1404, 2006 | 159 | 2006 |
| Making change last: applying the NHS institute for innovation and improvement sustainability model to healthcare improvement C Doyle, C Howe, T Woodcock, R Myron, K Phekoo, C McNicholas, ... Implementation Science 8, 1-10, 2013 | 143 | 2013 |
| Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients GJ Morgan, SA Schey, P Wu, M Srikanth, KJ Phekoo, M Jenner, ... British journal of haematology 137 (3), 268-269, 2007 | 135 | 2007 |
| The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study SA Schey, GJ Morgan, K Ramasamy, B Hazel, D Ladon, S Corderoy, ... British journal of haematology 150 (3), 326-333, 2010 | 78 | 2010 |
| ACCORD: a multicentre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple candidate agents for the treatment of COVID-19 in … T Wilkinson, R Dixon, C Page, M Carroll, G Griffiths, LP Ho, A De Soyza, ... Trials 21, 1-3, 2020 | 68 | 2020 |
| Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study G AlJuburi, AA Laverty, SA Green, KJ Phekoo, D Bell, A Majeed Journal of public health 35 (4), 510-517, 2013 | 68 | 2013 |
| The incidence and survival of Waldenström's Macroglobulinaemia in South East England KJ Phekoo, RH Jack, E Davies, H Møller, SA Schey, ... Leukemia research 32 (1), 55-59, 2008 | 54 | 2008 |
| Folate assays: serum or red cell? K Phekoo, Y Williams, SA Schey, VE Andrews, JM Dudley, AV Hoffbrand Journal of the Royal College of Physicians of London 31 (3), 291, 1997 | 40 | 1997 |
| A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11 E Pizzo, AA Laverty, KJ Phekoo, G AlJuburi, SA Green, D Bell, A Majeed Journal of Public Health 37 (3), 529-539, 2015 | 36 | 2015 |
| Trends in hospital admissions for sickle cell disease in England, 2001/02–2009/10 G AlJuburi, AA Laverty, SA Green, KJ Phekoo, R Banarsee, NVO Okoye, ... Journal of Public Health 34 (4), 570-576, 2012 | 35 | 2012 |
| Consultant Haematologists, South Thames Haematology Specialist Committee. A population study to define the incidence and survival of multiple myeloma in a National Health … P KJ Br J Haematol 127, 299-304, 2004 | 31 | 2004 |
| Clinical evaluation of the Determine HIV-1/2 Ag/Ab combo test CB Jones, K Kuldanek, D Muir, K Phekoo, A Black, R Sacks, A Smith, ... The Journal of infectious diseases 206 (12), 1947-1949, 2012 | 27 | 2012 |
| Patients’ views on improving sickle cell disease management in primary care: focus group discussion G AlJuburi, KJ Phekoo, NVO Okoye, K Anie, SA Green, A Nkohkwo, ... JRSM short reports 3 (12), 1-7, 2012 | 25 | 2012 |
| Audit of practice in platelet refractoriness KJ Phekoo, H Hambley, SA Schey, N Win, R Carr, MF Murphy Vox sanguinis 73 (2), 81-86, 1997 | 23 | 1997 |
| Views of patients about sickle cell disease management in primary care: a questionnaire-based pilot study GA Juburi, O Okoye, A Majeed, Y Knight, SA Green, R Banarsee, ... JRSM short reports 3 (11), 1-5, 2012 | 20 | 2012 |
| Comparison of a specialist haematological malignancy database against a regional cancer registry: case ascertainment and diagnostic accuracy K Phekoo, H Møller, M Richards, S Schey British journal of haematology 119 (3), 697-705, 2002 | 15 | 2002 |
| Acceptability and necessity of HIV and other blood-borne virus testing in a psychiatric setting C Sanger, J Hayward, G Patel, K Phekoo, AJ Poots, C Howe, ... The British Journal of Psychiatry 202 (4), 307-308, 2013 | 14 | 2013 |
| CRD: a phase 1 dose escalation study to determine the maximum tolerated dose of cyclophosphamide in combination with lenalidomide and dexamethasone in relapsed/refractory myeloma S Schey, GJ Morgan, K Ramasamy, B Hazel, K Phekoo, S Corderoy, ... Blood 112 (11), 3707, 2008 | 14 | 2008 |
| Characterizing emergency admissions of patients with sickle cell crisis in NHS brent: observational study SA Green, G AlJuburi, A Majeed, O Okoye, C Amobi, R Banarsee, ... JRSM short reports 3 (6), 1-7, 2012 | 13 | 2012 |
Stuart Green HoferProject Evaluation ManagerVerified email at imperial.ac.uk
